Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03626701 · ClinicalTrials.gov registry record · NA
RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years
A NA study, sponsored by Avita Medical.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03626701 is a NA study that was terminated before completion, run by Avita Medical. The registered enrollment target is 19 participants.
The verdict
NCT03626701, a NA study, was terminated before completion, sponsored by Avita Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
A prospective, parallel-arm, randomized (1:1) multicenter trial to demonstrate that RECELL treatment of partial-thickness burn injuries, can safely and effectively increase the incidence of Day 10 healing compared with a standardized wound dressing.
Interventions
- DEVICE RES (Regenerative Epidermal Suspension) prepared using the RECELL® Autologous Cell Harvesting Device
- COMBINATION_PRODUCT Mepilex® Ag Wound Dressing
- PROCEDURE Conventional autografting (only when indicated)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2020-03-03 |
| Est. Completion | 2022-06-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03626701
The ClinicalTrials.gov registry entry for NCT03626701 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avita Medical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which RES (Regenerative Epidermal Suspension) prepared using the RECELL® Autologous Cell Harvesting Device is the first listed.
NCT03626701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03626701 about?
NCT03626701 is a clinical study titled "RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years". A prospective, parallel-arm, randomized (1:1) multicenter trial to demonstrate that RECELL treatment of partial-thickness burn injuries, can safely and effectively increase the incidence of Day 10 healing compared with a standardized wound dressing.
What is the current status of trial NCT03626701?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2020-03-03. Estimated completion is 2022-06-03.
What interventions are being tested in trial NCT03626701?
The interventions under investigation include: RES (Regenerative Epidermal Suspension) prepared using the RECELL® Autologous Cell Harvesting Device (DEVICE), Mepilex® Ag Wound Dressing (COMBINATION_PRODUCT), Conventional autografting (only when indicated) (PROCEDURE).
Who is sponsoring clinical trial NCT03626701?
This trial is sponsored by Avita Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.